These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8016883)
1. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin. Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883 [TBL] [Abstract][Full Text] [Related]
2. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts. Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants. Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124 [No Abstract] [Full Text] [Related]
4. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778 [TBL] [Abstract][Full Text] [Related]
5. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection). Räisänen-Sokolowski A; Myllärniemi M; Häyry P Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125 [No Abstract] [Full Text] [Related]
6. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471 [TBL] [Abstract][Full Text] [Related]
7. Effect of 15-deoxyspergualin on allograft arterio-sclerosis and growth factor synthesis in the rat. Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P Transpl Int; 1994; 7 Suppl 1():S376-7. PubMed ID: 11271256 [TBL] [Abstract][Full Text] [Related]
8. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Mennander A; Räisänen A; Paavonen T; Häyry P Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036 [TBL] [Abstract][Full Text] [Related]
9. Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat. Geerling RA; de Bruin RW; Scheringa M; Bonthuis F; Jeekel J; Ijzermans JN; Marquet RL Transplantation; 1994 Dec; 58(11):1258-63. PubMed ID: 7992371 [TBL] [Abstract][Full Text] [Related]
10. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Yuh DD; Morris RE Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226 [TBL] [Abstract][Full Text] [Related]
11. Rat aortic allografts: an experimental model for chronic transplant arteriosclerosis. Häyry P; Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T Transplant Proc; 1991 Feb; 23(1 Pt 1):611-2. PubMed ID: 1990624 [No Abstract] [Full Text] [Related]
12. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687 [TBL] [Abstract][Full Text] [Related]
14. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Räisänen-Sokolowski A; Vuoristo P; Myllärniemi M; Yilmaz S; Kallio E; Häyry P Transpl Immunol; 1995 Dec; 3(4):342-51. PubMed ID: 8665154 [TBL] [Abstract][Full Text] [Related]
15. Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis. Murata S; Sundell CL; Lijkwan MA; Balsam LB; Hammainen P; Coleman C; York C; Luchoomun J; Suen KL; Howard R; Somers PK; Morris RE; Robbins RC Transplantation; 2004 May; 77(10):1494-500. PubMed ID: 15239610 [TBL] [Abstract][Full Text] [Related]
16. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated. Mennander A; Paavonen T; Häyry P Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine. Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707 [TBL] [Abstract][Full Text] [Related]
19. Possible mechanism in rat with surviving heart allograft after short course of 15-deoxyspergualin treatment. Jiang H; Takahara S; Kyo M; Takano Y; Kokado Y; Ishibashi M; Sonoda T J Clin Lab Immunol; 1990 Jul; 32(3):131-6. PubMed ID: 1966949 [TBL] [Abstract][Full Text] [Related]
20. LF 08-0299 in the prophylaxis and treatment of chronic rejection in a rat aortic allograft model. Lácha J; Rossmann P; Lodererová A; Havlíèková J; Vítko S Transpl Int; 2000; 13 Suppl 1():S565-7. PubMed ID: 11112075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]